Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.6% ...

Investors led by Elon Musk offer $97.4 billion for OpenAI. Sam Altman replies: 'No thank you.' ...

US biotech major Gilead Sciences was trading nearly 5% higher in Wednesday’s pre-market trading after presenting its fourth ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

The S&P 500 dipped amid news of higher-than-expected U.S. inflation, dampening hopes for a Federal Reserve rate cut. Despite ...

The S&P 500 slipped after a strong U.S. inflation report dashed hopes for rate cuts. CVS Health and Gilead Sciences rose on positive earnings, contrasting Nvidia and Amazon's declines. President Trump ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Brent Greetham has been appointed chief financial officer at Surgical Innovations, with effect from 24 February 2025. Chris ...

In the assessment of 12-month price targets, analysts unveil insights for Gilead Sciences, presenting an average target of $99.32, a high estimate of $125.00, and a low estimate of $80.00. This ...

Cognizant (CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (GILD) that aims to ...